logo
S&P/TSX composite closes higher, U.S. stock markets mixed

S&P/TSX composite closes higher, U.S. stock markets mixed

Toronto Star6 hours ago

Canada's main stock index climbed higher on Wednesday and U.S. stock markets closed out the trading day mixed as investors digested an uncertain interest rate outlook south of the border.
The S&P/TSX composite index was up 18.46 points at 26,559.85.
In New York, the Dow Jones industrial average closed down 44.14 points at 42,171.66. The S&P 500 index was down 1.85 points at 5,980.87, while the Nasdaq composite was up 25.18 points at 19,546.27.
'The Federal Reserve rate decision is front and centre today,' said Angelo Kourkafas, senior investment strategist at Edward Jones.
ARTICLE CONTINUES BELOW
'The Fed remains squarely in wait-and-see mode as it waits to learn more about the impact of tariffs on inflation and the economy.'
The Fed kept its key rate unchanged for the fourth straight meeting Wednesday. The central bank is forecasting noticeably weaker growth, higher inflation and slightly higher unemployment at the end of this year than it had forecast in March, before U.S. President Donald Trump announced sweeping tariffs.
The tariffs announced April 2 have been put on hold until July 9.
Fed Chair Jerome Powell stressed all the uncertainty surrounding tariffs means the median forecast for two cuts to interest rates this year could end up being far from reality.
'Right now it's just a forecast in a very foggy time,' he said
'Because the economy is still solid, we can take the time to actually see what's going to happen.'
Oil prices moved sharply higher late last week as Israel began launching air assaults on several Iranian targets. There have not been any meaningful impacts to global crude oil supplies to date.
The August crude oil contract settled at US$73.50 a barrel, up 23 cents from a day earlier.
ARTICLE CONTINUES BELOW
ARTICLE CONTINUES BELOW
'Oil prices remain about five per cent below where they were last year. And we think that's the middle of the range where they have been over the past three years or two years,' said Kourkafas.
'So I think the market's getting some comfort that hopefully there's going to be some resolution to this. But that is another factor that is adding to the uncertainty.'
The Canadian dollar traded for 73.14 cents US compared with 73.51 cents US on Tuesday.
The July natural gas contract was up 14 cents US at US$3.99 per mmBTU.
The August gold contract was up US$1.20 at US$3,408.10 an ounce and the July copper contract was up four cents US at US$4.85 a pound.
This report by The Canadian Press was first published June 18, 2025.
Companies in this story: (TSX: GSPTSE, TSX: CADUSD)
— With files from The Associated Press.
Note to readers:This is a corrected story. A previous version included the incorrect settle price for oil.

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

AI is Top of Mind in Alithya's 2025 Industry Trends Reports for Manufacturing, Healthcare, and Financial Services
AI is Top of Mind in Alithya's 2025 Industry Trends Reports for Manufacturing, Healthcare, and Financial Services

Globe and Mail

time17 minutes ago

  • Globe and Mail

AI is Top of Mind in Alithya's 2025 Industry Trends Reports for Manufacturing, Healthcare, and Financial Services

ALPHARETTA, Ga., June 19, 2025 /CNW/ - Alithya Group, inc. (TSX: ALYA) ("Alithya") today announced the release of its 2025 Industry Trends Reports and Analysis across three critical sectors: manufacturing, healthcare, and financial services. Each report is based on a survey of industry professionals and offers exclusive insights into the key trends, challenges, and opportunities expected to shape business conditions in the next 12 months.

Google faces setback on EU fine as court adviser sides with regulators
Google faces setback on EU fine as court adviser sides with regulators

Global News

time20 minutes ago

  • Global News

Google faces setback on EU fine as court adviser sides with regulators

Google faced a big setback Thursday in its attempt to overturn a multibillion-dollar European Union antitrust penalty involving Android after a top court's legal adviser sided with regulators. The European Court of Justice's advocate general, Juliane Kokott, recommended in a non-binding opinion that Google's appeal against the fine worth more than four billion euros (US$4.7 billion) should be dismissed. The case dates back to 2018, when the EU's executive Commission slapped Google with a 4.134 billion euro fine after finding that the U.S. tech company used the dominance of its mobile Android operating system to throttle competition and reduce consumer choice. After Google filed an initial appeal, a lower court trimmed the penalty to 4.125 billion euros in 2022, which the company also appealed to the Court of Justice. Get daily National news Get the day's top news, political, economic, and current affairs headlines, delivered to your inbox once a day. Sign up for daily National newsletter Sign Up By providing your email address, you have read and agree to Global News' Terms and Conditions and Privacy Policy Kokott advised that the Court of Justice confirm the fine and uphold the lower court's judgment, according to a press release summarizing her opinion. Story continues below advertisement 1:25 Google could face Justice Department antitrust probe Google said it was disappointed with the opinion, adding that if the court follows it, it 'would discourage investment in open platforms and harm Android users, partners and app developers.' ″Android has created more choice for everyone and supports thousands of successful businesses in Europe and around the world,' the company said in a statement. Opinions from the advocate general aren't legally binding but are often followed by judges. The judges 'are now beginning their deliberations in this case. Judgment will be given at a later date,' the court said. The fine was one of three antitrust penalties totaling more than 8 billion euros that the European Commission slapped on Google in the last decade, as the 27-nation bloc launched its crackdown on Big Tech companies. Story continues below advertisement Google still faces a decision from Brussels in an antitrust case targeting its digital ad business.

Aurora Cannabis Advises of Second False Article from Investing.com
Aurora Cannabis Advises of Second False Article from Investing.com

Cision Canada

time24 minutes ago

  • Cision Canada

Aurora Cannabis Advises of Second False Article from Investing.com

NASDAQ| TSX: ACB EDMONTON, AB, June 19, 2025 /CNW/ - Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), a leading Canada-based global medical cannabis company, has become aware of a second instance of misinformation posted on news website, On June 18, 2025, Aurora advised the market that an article posted on incorrectly stated that Aurora had agreed to acquire New Zealand-based MedLeaf Therapeutics. Later in the day on June 18, 2025, a second article was posted on that incorrectly states that Aurora has entered into a strategic partnership with MediPharm GmbH for distribution of medical cannabis in Germany and other EU markets. The Company categorically denies both articles. Aurora has not entered into any such agreements, has had no discussions with MedLeaf Therapeutics or MediPharm GmbH with respect to any business combination transaction or strategic partnership, and has not made any statements or filed any information pertaining to any such transactions. The erroneous articles posted on state that they were generated "with the support of AI" and reviewed by an editor. The Company is launching an investigation into the genesis of these articles. In the meantime, Aurora confirms that it is not in possession of material non-public information and advises investors that should not be considered a credible source of information regarding the Company. Any information regarding material corporate transactions will be announced directly by the Company to the market as soon as it is appropriate to do so. About Aurora Cannabis Aurora is opening the world to cannabis, serving both the medical and consumer markets across Canada, Europe, Australia and New Zealand. Headquartered in Edmonton, Alberta, Aurora is a pioneer in global cannabis, dedicated to helping people improve their lives. The Company's adult-use brand portfolio includes Drift, San Rafael '71, Daily Special, Tasty's, Being and Greybeard. Medical cannabis brands include MedReleaf, CanniMed, Aurora and Whistler Medical Marijuana Co., as well as international brands, Pedanios, Bidiol, IndiMed and CraftPlant. Aurora also has a controlling interest in Bevo Farms Ltd., North America's leading supplier of propagated agricultural plants. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora's brands continue to break through as industry leaders in the medical, wellness and adult recreational markets wherever they are launched. Learn more at and follow us on X and LinkedIn. Aurora's common shares trade on the NASDAQ and TSX under the symbol "ACB". Forward Looking Information This news release includes statements containing certain "forward-looking information" within the meaning of applicable securities law (" forward-looking statements"). Forward-looking statements are frequently characterized by words such as "plan", "continue", "expect", "project", "intend", "believe", "anticipate", "estimate", "may", "will", "potential", "proposed" and other similar words, or statements that certain events or conditions "may" or "will" occur. These forward-looking statements are only predictions. Forward looking information or statements contained in this news release have been developed based on assumptions management considers to be reasonable. Material factors or assumptions involved in developing forward-looking statements include, without limitation, publicly available information from governmental sources as well as from market research and industry analysis and on assumptions based on data and knowledge of this industry which the Company believes to be reasonable. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements. These risks include, but are not limited to, the magnitude and duration of potential new or increased tariffs imposed on goods imported from Canada into the United States; the ability to retain key personnel, the ability to continue investing in infrastructure to support growth, the ability to obtain financing on acceptable terms, the continued quality of our products, customer experience and retention, the development of third party government and non-government consumer sales channels, management's estimates of consumer demand in Canada and in jurisdictions where the Company exports, expectations of future results and expenses, the ability to expand and maintain distribution capabilities, the impact of competition, the general impact of financial market conditions, the yield from cannabis growing operations, product demand, changes in prices of required commodities, competition, and the possibility for changes in laws, rules, and regulations in the industry, epidemics, pandemics or other public health crises and other risks, uncertainties and factors set out under the heading "Risk Factors" in the Company's annual information form dated June 17, 2025 (the "AIF") and filed with Canadian securities regulators available on the Company's issuer profile on SEDAR+ at and filed with and available on the SEC's website at The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law. SOURCE Aurora Cannabis Inc.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store